dihexa nootropic Synapse (Dihexa) Cognitive Peptide Therapy Lincoln Park Dihexa (PNB-0408) | c-Met/HGFR Activator

Due to the compounds plasma half-life of approximately 3.86.9 hours [5] , twice-daily (BID) dosing may provide more sustained NNMT inhibition

E., Opoku, K

Problem: Redness and Irritation Mild redness immediately after application can be normal, especially with higher concentrations

Anecdotal reports from users have included: Commonly Reported: Injection site pain, redness, or swelling Mild dizziness Nausea Fatigue or drowsiness Less Commonly Reported: Anxiety or mood changes Heart palpitations Insomnia Loss of appetite Depression or anhedonia The FDA has noted that BPC-157 may pose an immunogenicity risk (triggering an immune response)